We provide you with 20 years of free, institutional-grade data for COCP stock, allowing you to gain comprehensive visibility into the fundamentals of the company. This in-depth information is essential for making informed investment decisions and understanding the financial health and performance of COCP. Explore the full financial landscape of COCP stock.
| Reported Date | CIK | Ticker | Type |
|---|
Cocrystal Pharma, Inc(NASDAQ:COCP) 
Cocrystal Pharma, Inc., a biotechnology company, focuses on the discovery and development of antiviral therapeutic treatments for serious and/or chronic viral diseases. It employs structure-based technologies to create antiviral drugs primarily to treat hepatitis C virus (HCV), influenza virus, coro...
Website: http://www.cocrystalpharma.com
Founded: 2006
Full Time Employees: 11
Sector: Healthcare
Industry: Biotechnology
The information provided in this report about COCP stock is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.